PATH | VRL
Menu

Efficacy of the Human Rotavirus Vaccine RIX4414 in Malnourished Children

This study, published in the Journal of Infectious Diseases, determined that the Rotarix® vaccine produced by GlaxoSmithKline decreased the incidence severe gastroenteritis caused by rotavirus at comparable rates among well-nourished and malnourished children.

Author: Perez-Schael I, Salinas B, Tomat M, et al.

Published: 2007

» Visit web page (English)

(Located at www.journals.uchicago.edu)

Citation: Perez-Schael I, Salinas B, Tomat M, et al. Efficacy of the Human Rotavirus Vaccine RIX4414 in Malnourished Children. Journal of Infectious Diseases. 2007;196:537-540.

Resource types: Peer-reviewed journal

Diseases/vaccines: Rotavirus

Topics: Disease/vaccine specific information

Regions: Global